These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 2970231)

  • 1. Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors.
    Walker BR; Childs ME; Adams EM
    Am J Physiol; 1988 Aug; 255(2 Pt 2):H261-5. PubMed ID: 2970231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of arginine vasopressin on isolated guinea pig heart function during perfusion at constant flow and constant pressure.
    Graf BM; Fischer B; Martin E; Bosnjak ZJ; Stowe DF
    J Cardiovasc Pharmacol; 1997 Jan; 29(1):1-7. PubMed ID: 9007663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of selective arginine vasopressin V1 and V2 receptor antagonists on burn shock in the rat.
    Sun K; Lin BC; Wang CH; Zhu HN
    Cardiovasc Res; 1991 Apr; 25(4):265-9. PubMed ID: 1884385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP.
    Kopia GA; Valocik RE
    J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary vasoconstriction produced by vasopressin in anesthetized goats. Role of vasopressin V1 and V2 receptors and nitric oxide.
    Fernández N; García JL; García-Villalón AL; Monge L; Gómez B; Diéguez G
    Eur J Pharmacol; 1998 Jan; 342(2-3):225-33. PubMed ID: 9548390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct cardiac effects of vasopressin and their reversal by a vascular antagonist.
    Boyle WA; Segel LD
    Am J Physiol; 1986 Oct; 251(4 Pt 2):H734-41. PubMed ID: 3766750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin.
    Ervin MG; Ross MG; Leake RD; Fisher DA
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R636-43. PubMed ID: 1566929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats.
    Federico P; Veale WL; Pittman QJ
    Am J Physiol; 1992 May; 262(5 Pt 2):R901-8. PubMed ID: 1534208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New antagonists of the vasopressin receptor mediated contraction in rat tail artery.
    Petrusewicz J; Damasiewicz B; Kaliszan R; Juzwa W; Lammek B; Derdowska I
    Pharmacol Res; 1992; 25(2):167-72. PubMed ID: 1386154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart.
    Ouattara A; Landi M; Le Manach Y; Lecomte P; Leguen M; Boccara G; Coriat P; Riou B
    Anesthesiology; 2005 Jan; 102(1):85-92. PubMed ID: 15618791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery.
    Clineschmidt BV; Lis EV
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of V2 vasopressin agonist and antagonists on blood pressure regulation in normotensive (WKY) and spontaneously hypertensive (SHR) rats.
    Budzikowski A; Lon S; Paczwa P; Szczepanska-Sadowska E
    J Auton Nerv Syst; 1992 Jun; 39(2):87-95. PubMed ID: 1430797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin-mediated forearm vasodilation in normal humans. Evidence for a vascular vasopressin V2 receptor.
    Hirsch AT; Dzau VJ; Majzoub JA; Creager MA
    J Clin Invest; 1989 Aug; 84(2):418-26. PubMed ID: 2527249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a vasodilatory effect of vasopressin in the conscious rat.
    Walker BR
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H34-9. PubMed ID: 3755295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking effects of V1 (OPC-21268) and V2 (OPC-31260) antagonists on the negative inotropic response to vasopressin in isolated dog heart preparations.
    Furukawa Y; Takayama S; Ren LM; Sawaki S; Inoue Y; Chiba S
    J Pharmacol Exp Ther; 1992 Nov; 263(2):627-31. PubMed ID: 1331408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V1 vs. combined V1+V2 vasopressin blockade after hemorrhage in conscious dogs.
    Liard JF
    Am J Physiol; 1988 Dec; 255(6 Pt 2):H1325-9. PubMed ID: 2974249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central effects of vasopressin and 1-desamino-8-D-arginine vasopressin (DDAVP) on interleukin-1 fever in the rat.
    Naylor AM; Gubitz GJ; Dinarello CA; Veale WL
    Brain Res; 1987 Jan; 401(1):173-7. PubMed ID: 2949799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.